In addition to PDAC, ARID1A is also frequently mutated in other cancer types, with 45.2% mutation rate in ovarian cancer, 18.7% in gastric cancer, 18.6% in bladder cancer, 13.7% in hepatocellular cancer, 11.5% in melanoma, 9.4% in colorectal cancer, 8.2% in lung cancer, and 2.5% in breast cancer (Kadoch et al., 2013). The gene discussed is ARID1A; the disease is cancer.